Mangalam Drugs and Organics MD, chairman, board of directors and AGM
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 0.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,55176.4% delivered
Mangalam Drugs and Organics board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorGOVARDHAN MURLIDHAR DHOOT
6 directors3 independent2 executive1 non-executive
- GOVARDHAN MURLIDHAR DHOOT · Chairperson and managing directorExecutive · joined Apr 1996 · reappointed Nov 2024 · 1 listed board · 2 committee seats
- BRIJMOHAN MURLIDHAR DHOOTExecutive · joined May 2015 · reappointed Aug 2024 · 1 listed board · 1 committee seat
- NIDHI SHANTANU MUNDADAIndependent · joined May 2018 · reappointed May 2023 · 100 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- PRAVEEN SAXENAIndependent · joined Mar 2021 · reappointed Mar 2026 · 66 months as independent · 1 listed board · 1 as independent · 1 committee seat
- RAKESH KISHINCHAND MILWANINon-executive · joined Mar 2022 · reappointed Mar 2022 · 54 months as independent · 1 listed board
- PRABHAKAR RAGHUNATH ZAVARIndependent · joined Sep 2026 · 0 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- RUKMESH PRABHUKUMAR DHANDHANIA, left 16 Jan 2026: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 15 Sep 20265 of 5 present2 independent · 33 days in between
- 12 Aug 20265 of 5 present2 independent · 89 days in between
- 14 May 20265 of 5 present2 independent
Audit Committee
Chair NIDHI SHANTANU MUNDADA
GOVARDHAN MURLIDHAR DHOOT, PRAVEEN SAXENA
- 12 Aug 20263 of 3 present2 independent · 89 days in between
- 14 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair NIDHI SHANTANU MUNDADA
PRAVEEN SAXENA, RAKESH KISHINCHAND MILWANI
- 15 Sep 20263 of 3 present2 independent · 123 days in between
- 14 May 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair NIDHI SHANTANU MUNDADA
GOVARDHAN MURLIDHAR DHOOT, BRIJMOHAN MURLIDHAR DHOOT
- 14 May 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- M/s V.S. Somani & Co.Peer-review certificate valid to Jul 2027
1 earlier auditor
- V . S. SOMANI and CO.Named in the filing for the quarter to Jun 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Mangalam Drugs and Organics AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Mangalam Drugs and Organics dividend history
Annual general meeting, 23 Sep 2026
24,367 shareholders on the register on 16 Sep 2026; present: 12 promoters and 37 others; votes counted by M/S BMM & ASSOCIATES / B.M. Maheshwari.The company's voting result (opens in a new tab)
TO CONSIDER AND ADOPT THE STANDALONE AND CONSOLIDATED AUDITED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026 TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS’ AND AUDITOR’S THEREON.MoreLess
Ordinary99.99% for0.01% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.97%
Turnout: all 36.31% · promoters 100.00% · institutions 98.28% · other public 0.85%
- TO APPOINT SHRI GOVARDHAN MURLIDHAR DHOOT (DIN: 01240086) AS EXECUTIVE DIRECTOR, WHO RETIRES BY ROTATION AND BEING ELIGIBLE, HAS OFFERS HIMSELF FOR RE-APPOINTMENT.Ordinary99.97% for0.03% against
Against: promoters 0.00% · institutions 0.00% · other public 2.01%
Turnout: all 36.31% · promoters 100.00% · institutions 98.28% · other public 0.85%
- TO APPOINT M/S S.N. NANDA AND CO., CHARTERED ACCOUNTANTS AS STATUTORY AUDITORS FOR A PERIOD OF FIVE CONSECTIVE YEARS AND FIX THEIR REMUNERATION.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.97%
Turnout: all 36.31% · promoters 100.00% · institutions 98.28% · other public 0.85%
- TO RATIFY REMUNERATION PAYABLE TO RAMPURAWALA MOHAMMED A & CO. (COST ACCOUNTANTS), THE COST AUDITORS OF THE COMPANY FOR FINANCIAL YEAR 2026-27:Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 1.08%
Turnout: all 36.31% · promoters 100.00% · institutions 98.28% · other public 0.85%
- TO APPROVE THE MATERAILITY OF RELATED PARTY TRANSACTIONSOrdinaryPromoters have an interest in it82.36% for17.64% against
Against: promoters 0.00% · institutions 100.00% · other public 1.01%
Turnout: all 0.66% · promoters 0.00% · institutions 98.28% · other public 0.85%
- TO APPOINT M/S L. N. JOSHI & CO., AS SECRETARIAL AUDITORS OF THE COMPANY FROM THE CONCLUSION 0F 53RD ANNUAL GENERAL MEETING TILL THE CONCLUSION OF 58TH ANNUAL GENERAL MEETING OF THE COMPANYSpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.97%
Turnout: all 36.31% · promoters 100.00% · institutions 98.28% · other public 0.85%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 17 Jun 2026, 1 resolution
25,235 shareholders on the register on 15 May 2026; votes counted by BMM & ASSOCIATES / Mr. B. M. Maheshwari.The company's voting result (opens in a new tab)
- APPROVAL FOR THE RE-APPOINTMENT OF SHRI. PRAVEEN SAXENA (DIN: 03199264) AS AN INDEPENDENT DIRECTOR OF THE COMPANY FOR A SECOND TERM OF FIVE CONSECUTIVE YEARS.Special99.95% for0.05% against
Against: promoters 0.00% · institutions 0.00% · other public 2.35%
Turnout: all 28.43% · promoters 77.78% · institutions 34.49% · other public 0.92%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Sep 2025, 5 resolutions
20,221 shareholders on the register on 22 Sep 2025; present: 16 promoters and 30 others; votes counted by BMM & ASSOCIATES / Mr. B. M. Maheshwari.The company's voting result (opens in a new tab)
TO CONSIDER AND ADOPT THE STANDALONE AND CONSOLIDATED AUDITED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2025 TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS’ AND AUDITOR’S THEREONMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.23%
Turnout: all 46.02% · promoters 90.25% · institutions 77.00% · other public 1.04%
- TO APPOINT A DIRECTOR IN PLACE OF SHRI BRIJMOHAN M. DHOOT (DIN: 01046420) WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENTOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.37%
Turnout: all 46.02% · promoters 90.25% · institutions 77.00% · other public 1.04%
- TO RATIFY REMUNERATION PAYABLE TO RAMPURAWALA MOHAMMED A & CO. - COST ACCOUNTANTS, THE COST AUDITORS OF THE COMPANY FOR FINANCIAL YEAR 2025-26Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 1.07%
Turnout: all 46.02% · promoters 90.25% · institutions 77.00% · other public 1.04%
- TO APPROVE MATERIAL RELATED PARTY TRANSACTIONSOrdinaryPromoters have an interest in it81.95% for18.05% against
Against: promoters 0.00% · institutions 100.00% · other public 0.42%
Turnout: all 0.62% · promoters 0.00% · institutions 77.00% · other public 1.04%
- TO APPOINT RAGINI CHOKSHI & CO., AS THE SECRETARIAL AUDITOR OF THE COMPANY FOR THE PERIOD OF 5 YEARS BEGINNING FROM 1ST APRIL, 2025 TILL 31ST MARCH, 2030Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.23%
Turnout: all 46.02% · promoters 90.25% · institutions 77.00% · other public 1.04%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Meeting called by the tribunal, 12 Aug 2025, 1 resolution
20,081 shareholders on the register on 5 Aug 2025; present: 13 promoters and 29 others; votes counted by Venugopal Prasad Rao / Venugopal Prasad Rao.The company's voting result (opens in a new tab)
TO CONSIDER, AND IF THOUGHT FIT, TO PASS WITH REQUISITE MAJORITY THE RESOLUTION OF APPROVAL OF PROPOSED MERGER EMBODIES IN SCHEME OF MERGER BY ABSORPTION OF MANGALAM LABORATORIES PRIVATE LIMITED ("MLPL” OR "FIRST TRANSFEROR COMPANY") AND SHRI JB PHARMA PRIVATE LIMITED (FORMERLY KNOWN AS SHRI JB PHARMA LLP) ("SJPPL” OR "SECOND TRANSFEROR COMPANY") WITH MANGALAM DRUGS AND ORGANICS LIMITED ("MDOL" OR "TRANSFEREE COMPANY") AND THEIR RESPECTIVE SHAREHOLDERS.MoreLess
Special100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.08%
Turnout: all 38.79% · promoters 76.48% · institutions 98.28% · other public 0.42%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 26 Sep 2024, 5 resolutions
Present: 16 promoters and 46 others.The company's voting result (opens in a new tab)
CONSIDERATION AND ADOPTION OF THE STANDALONE AND CONSOLIDATED AUDITED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2024, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS’ AND AUDITOR’S THEREONMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.18%
Turnout: all 38.86% · promoters 76.12% · institutions 0.00% · other public 1.16%
- APPOINTMENT OF A DIRECTOR IN PLACE OF SHRI RAKESH KISHINCHAND MILWANI (DIN: 01115469) WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENTOrdinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 1.31%
Turnout: all 38.86% · promoters 76.12% · institutions 0.00% · other public 1.16%
- APPROVAL OF RE-APPOINTMENT OF SHRI GOVARDHAN M. DHOOT, MANAGING DIRECTOR OF THE COMPANY FOR ANOTHER TERM OF 3 YEARS W.E.F. 01ST NOVEMBER 2024 TILL 31ST OCTOBER 2027SpecialPromoters have an interest in it97.95% for2.05% against
Against: promoters 0.00% · institutions 0.00% · other public 2.05%
Turnout: all 0.57% · promoters 0.00% · institutions 0.00% · other public 1.16%
- APPROVAL OF RE-APPOINTMENT OF SHRI BRIJMOHAN M. DHOOT, WHOLE TIME DIRECTOR OF THE COMPANY FOR ANOTHER TERM OF 3 YEARS W.E.F. 14TH AUGUST 2024 TILL 13TH AUGUST 2027SpecialPromoters have an interest in it97.95% for2.05% against
Against: promoters 0.00% · institutions 0.00% · other public 2.05%
Turnout: all 0.57% · promoters 0.00% · institutions 0.00% · other public 1.16%
- RATIFICATION OF REMUNERATION PAYABLE TO RAMPURAWALA MOHAMMED A & CO. - COST ACCOUNTANTS, THE COST AUDITORS OF THE COMPANY FOR FINANCIAL YEAR 2024-25Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 1.21%
Turnout: all 38.86% · promoters 76.12% · institutions 0.00% · other public 1.15%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Sep 2023, 4 resolutions
Present: 17 promoters and 47 others.The company's voting result (opens in a new tab)
- TO CONSIDER AND ADOPT THE STANDALONE AUDITED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED MARCH 31, 2023 TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON.Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 5.96%
Turnout: all 48.54% · promoters 96.18% · institutions 0.00% · other public 0.30%
- TO APPOINT A DIRECTOR IN PLACE OF SHRI GOVARDHAN M. DHOOT WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENT.Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 7.60%
Turnout: all 48.54% · promoters 96.18% · institutions 0.00% · other public 0.30%
- TO APPROVE MATERIAL RELATED PARTY TRANSACTIONS.OrdinaryPromoters have an interest in it93.67% for6.33% against
Against: promoters 0.00% · institutions 0.00% · other public 6.33%
Turnout: all 0.15% · promoters 0.00% · institutions 0.00% · other public 0.30%
- TO RATIFY REMUNERATION PAYABLE TO RAMPURAWALA MOHAMMED A & CO.- COST ACCOUNTANTS, THE COST AUDITORS OF THE COMPANY FOR THE FINANCIAL YEAR 2023-24Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 7.05%
Turnout: all 48.54% · promoters 96.18% · institutions 0.00% · other public 0.30%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 30 Apr 2023, 2 resolutions
The company's voting result (opens in a new tab)
- To approve the re-appointment of Mrs. Nidhi S. Mundada (DIN: 08134952) as an Independent Director of the Company for a second term of five consecutive yearsSpecial99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 1.54%
Turnout: all 48.88% · promoters 96.18% · institutions 0.00% · other public 0.98%
- To approve continuation of Shri Govardhan Murlidhar Dhoot (DIN: 01240086) as a Managing Director of the Company on attaining age of seventy years.SpecialPromoters have an interest in it99.96% for0.04% against
Against: promoters 0.00% · institutions 0.00% · other public 1.56%
Turnout: all 20.16% · promoters 39.11% · institutions 0.00% · other public 0.98%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 28 Sep 2022, 10 resolutions
Present: 15 promoters and 57 others.The company's voting result (opens in a new tab)
- To consider and adopt the standalone audited financial statements for the Financial Year ended March 31, 2022 together with the reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.15%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
- TO APPOINT A DIRECTOR IN PLACE OF SHRI BRIJMOHAN M. DHOOT (DIN: 01046420) WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENT.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.43%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
- TO RATIFY REMUNERATION PAYABLE TO RAMPURAWALA MOHAMMED A & CO. - COST ACCOUNTANTS, THE COST AUDITORS OF THE COMPANY FOR THE FINANCIAL YEAR 2022-23.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.49%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
- TO APPROVE THE RE-APPOINTMENT OF SHRI RUKMESH P. DHANDHANIA (DIN: 02493968) AS AN INDEPENDENT DIRECTOR OF THE COMPANY FOR A SECOND TERM OF FIVE CONSECUTIVE YEARS.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 2.08%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
- TO APPROVE THE INCREASE IN BORROWING POWERS OF THE BOARD OF DIRECTORS UNDER SECTION 180(1)(C) AND 180(1)(A) OF THE COMPANIES, ACT, 2013.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 1.83%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
- TO APPROVE THE INCREASE IN THE LIMITS APPLICABLE FOR MAKING INVESTMENTS / EXTENDING LOANS AND GIVING GUARANTEES OR PROVIDING SECURITIES IN CONNECTION WITH LOANS TO PERSONS / BODIES CORPORATE.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 1.40%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
- TO APPROVE GIVING LOAN OR GUARANTEE OR PROVIDING SECURITY IN CONNECTION WITH LOAN AVAILED BY ANY OTHER PERSON SPECIFIED UNDER SECTION 185 OF THE COMPANIES ACT, 2013.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 1.32%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
- TO APPROVE MATERIAL RELATED PARTY TRANSACTIONSOrdinaryPromoters have an interest in it99.56% for0.44% against
Against: promoters 0.00% · institutions 0.00% · other public 0.44%
Turnout: all 0.16% · promoters 0.00% · institutions 0.00% · other public 0.32%
- TO ADOPT NEW MEMORANDUM OF ASSOCIATION AS PER COMPANIES ACT, 2013.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.44%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
- TO ADOPT NEW SET OF ARTICLES OF ASSOCIATION AS PER COMPANIES ACT, 2013.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.44%
Turnout: all 39.38% · promoters 77.78% · institutions 0.00% · other public 0.32%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Stakes in unlisted companies
Reported in the filing for the quarter to Sep 2026.
- Unlisted stake heldMANGALAM LABORATORIES PRIVATE LIMITEDSince 30 Sep 2023
0.00% bought in the quarter; holding 100.00%, from 100.00%
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- No
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.